Immunovia AB (publ) (STO:IMMNOV)
Sweden · Delayed Price · Currency is SEK 0.1296
-0.0022 (-1.67%)
Sep 4, 2026, 5:29 PM CET
Immunovia AB Market Cap
Immunovia AB has a market cap or net worth of 87.18 million as of September 4, 2026. Its market cap has decreased by -61.09% in one year.
Market Cap
87.18M
Enterprise Value
55.55M
Revenue
1.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.13
ChartMarket Cap Chart
Since December 1, 2015, Immunovia AB's market cap has decreased from 424.45M to 87.18M, a decrease of -79.46%. That is a compound annual growth rate of -13.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 87.18M | -42.91% |
| Dec 30, 2025 | 152.70M | 64.79% |
| Dec 30, 2024 | 92.66M | 15.47% |
| Dec 29, 2023 | 80.25M | -86.52% |
| Dec 30, 2022 | 595.21M | -64.93% |
| Dec 30, 2021 | 1.70B | -37.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 158.02B |
| Getinge AB | 66.73B |
| Sectra AB | 55.18B |
| Medicover AB | 37.08B |
| Vivesto AB | 99.64M |
| Annexin Pharmaceuticals AB | 95.65M |
| Spago Nanomedical AB | 89.82M |
| IDL Diagnostics AB | 89.61M |